$41.94
Today
as of Jul 22, 16:46 ET
Last 30 days
Recent Press Releases & News
ASTH: Lowering target price to $48.00
Astrana Health (ASTH) Stock Looks Fully Valued Following Its 87% Run
2 Reasons to Like ASTH and 1 to Stay Skeptical
Overview
52-week range
$18
$40
100% of range
Avg surprise (last 3)
+22.9%
Avg reaction (last 2)
+3.2%
100% positive
Latest IV / EM
76%
EM ±17.3% · $40 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $0.74 | $0.29 | +155.2% | +428.6% | +2.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.01 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $0.19 | $0.36 | -47.2% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $0.14 | $0.23 | -39.1% | — | +4.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.33 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.40 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.31 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.47 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.28 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | AMC | $0.33 | $0.19 | +73.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $29M | — | $19M | $20M | $21M | — | $28M | $30M |
| Net income | $14M | — | $373,000 | $9M | $7M | — | $16M | $19M |
| EPS (diluted) | $0.29 | — | $0.01 | $0.19 | $0.14 | — | $0.33 | $0.40 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $478M | $429M | $462M | $340M | $259M | $288M | $348M | $325M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $1.00B | $863M | $884M | $729M | $613M | $638M | $597M | $570M |
| Total assets | $2.36B | $2.22B | $2.24B | $1.44B | $1.33B | $1.35B | $1.29B | $1.25B |
| Long-term debt | $980M | $991M | $1.00B | $401M | $404M | $425M | $423M | $425M |
| Total liabilities | $1.78B | $1.66B | $1.68B | $904M | $814M | $841M | $778M | $774M |
| Total equity | $800M | $779M | $776M | $765M | $745M | $713M | $705M | $679M |